 |
18 Diseases |  |
0 Trials |
|
0 Trials |  |
1 News |  |
- HB-110E / Genexine
Trial completion, Combination therapy: Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E (clinicaltrials.gov) - Dec 25, 2013
P=N/A, N=6, Completed, Sponsor: Genexine, Inc.
Active, not recruiting --> Completed